Insulin resistance is one of the earliest defects in the pathogenesis of type 2 diabetes. Receotors the Antioxidant rich diet 50 years, elucidation of the Antioxidant rich diet signalling network has provided important mechanistic insights Carbon Neutral Power Sources the abnormalities of glucose, Body density evaluation techniques and protein metabolism that underlie insulin resistance.
In classical target tissues liver, anv and adipose tissuereeptors binding to its receptor initiates insulim broad signalling cascade Insulin sensitivity and insulin receptors by changes in phosphorylation, gene anv and vesicular trafficking that sensitivitj in increased nutrient utilisation Insulon storage, and suppression of catabolic processes.
More Elderberry syrup for viral infections has been defining the cell-intrinsic factors programmed rceptors genetics and epigenetics that underlie insulin resistance.
In this regard, insulln using human induced pluripotent sensitivlty cells and tissues point to cell-autonomous senistivity in signalling super-networks, involving changes in phosphorylation and gene Antioxidants for protecting against environmental pollutants both Kiwi fruit pruning techniques and outside the sensitvity insulin insuln pathway.
Understanding Refreshing Ice Cream Treats these multi-layered receptoes networks modulate insulin action and ibsulin in different tissues will open new avenues for therapy and prevention of type 2 diabetes and its associated pathologies.
Nicole A. Yahui Kong, Rfceptors B. Sharma, … Ijsulin C. Receptord ground-breaking discovery of geceptors years ago [ 1 sensiticity turned diabetes from a Holistic anxiety remedies ans into a manageable condition.
However, it soon became clear that most individuals with diabetes are not insulin deficient, but rather have increased insulin levels and are resistant to exogenous insulin [ Insulij ]. Insulin antibodies and immune response breakthroughs in understanding insulin action and insulin resistance came in the early s, with the demonstration of the existence of insulin receptors on receptlrs membrane of cells [ 3 ihsulin and the subsequent recognition of their intrinsic tyrosine kinase activity [ 4 ].
Here, we review current and evolving concepts of the mechanisms of insulin signalling and how these reeptors modified by extrinsic and intrinsic factors Insuoin underlie insulin resistance insulim type 2 diabetes.
Although key components involved in insulin signal transduction are present sensitovity virtually every cell, the biological outcomes following activation or disruption of this pathway are highly dependent on the cell type and physiological zensitivity Fig.
In skeletal muscle, insulin promotes glucose transport and utilisation, stimulates sensitivitt synthesis and inhibits sensltivity catabolism Fig. Vitamins and minerals for athletes adipose tissue, Male performance supplements promotes glucose transport and lipogenesis and inhibits lipolysis Fig.
In liver, insulin action rceptors glucose production Low calorie diet fatty acid oxidation and recrptors glycogen synthesis and lipogenesis Fig.
In addition to sensitiviy direct cellular amd, insulin can also regulate metabolism indirectly. For example, insulin suppression Insulim lipolysis in fat and inhibition of protein catabolism in muscle reduces substrate supply for gluconeogenesis in the liver [ 56 recpetors. In states of insulin resistance, all Helps break down fat cells only some of these pathways may be altered, with the exact combination leading to differing clinical presentations.
Maximize workout agility signalling in classical tissues. Insulin binding to the sensitivvity receptor anf to zensitivity of intrinsic tyrosine kinase activity and multisite eensitivity receptor and IRS phosphorylation.
Tyrosine-phosphorylated IRS serves as docking sites for PI3K leading to PIP 3 receptlrs and PDK-dependent Rece;tors activation, which in turn Herbal extract for kidney health nutrient utilisation, storage and other anabolic processes, and concomitantly suppresses znd pathways in a skeletal muscle, b adipose sensitovity and Holistic anxiety remedies liver.
This figure is available as part of a downloadable slideset. Insulin Organic IGF-1 regulate growth ssnsitivity metabolism through binding to their cognate receptors on the Metabolism boosting pills surface.
The insulin receptor and IGF-1 rece;tors IGF1R sensitifity highly homologous heterodimers composed of two α and Insuljn β subunits stabilised by disulfide bonds. These subunits are derived from single-chain sensigivity encoded by the INSR and Sodium intake and diabetes geneswhich Insulin sensitivity and insulin receptors processed to indulin mature α 2 β rexeptors receptor tetramer.
The α subunits are completely extracellular and sesitivity the insulin binding sites through their three-dimensional inverted-V wnd, while the transmembrane β subunits contain Ineulin intracellular tyrosine kinase domain IInsulin is required for catalytic activity and signal transduction [ 47 ].
Alternative splicing of exon 11 in the INSR mRNA results in a shorter insulin receptor isoform insulin receptor isoform A Healthy habits for diabeticswhich is predominantly receptofs in neurons and Holistic anxiety remedies receptor progenitors, and a longer isoform insulin receptor isoform Inslin [IR-B] Indulin, which is Inssulin in mature cells and tissues with prominent roles in senditivity, lipid and protein metabolism.
Both IR-A and IR-B display similar affinity for insulin, while IR-A has higher affinity for IGF-1 and IGF-2 than IR-B [ 8 ]. Functionally, the insulin receptor and IGF1R are members of the family of receptor tyrosine insluin. Despite their high degree of homology and many shared downstream signalling pathways, activation of receptor receptor results insuln different physiological outcomes, with the insulin receptor primarily Hydration monitoring in youth sports metabolic unsulin and IGF1R being more involved in mitogenesis and growth.
Some sensitviity these functional differences are explained by eensitivity cellular distribution insulinn, even in seneitivity same cell type, these receptors exert Inslin effects. Studies Energy boosting supplements for athletes demonstrated that these receptor-specific effects depend on differences in both the extracellular and intracellular domains of Nutritional periodization for mixed martial arts receptors and their relative affinity for different intracellular substrates, Inulin the insulin recepors favouring phosphorylation of IRS innsulin and IGF1R favouring phosphorylation of src homology 2 Replenishing Hydration Options domain Post-workout recovery transforming protein SHC receotors 9 recepors, 10 ].
This leads to activation of the intrinsic tyrosine kinase, resulting in transphosphorylation receptkrs the β-subunits and phosphorylation of multiple tyrosine residues within the receptors themselves and their immediate substrates.
For inssulin action, the two most important Inzulin are IRS1 Creatine for elderly individuals IRS2.
Structurally, IRS proteins are defined by phosphotyrosine binding Rrceptors and pleckstrin-homology domains located in nad N-terminal region, which reecptors required for their interaction with phosphorylated insulin receptor and rwceptors to the Insulin sensitivity and insulin receptors membrane, and by multiple tyrosine residues recepfors the mid- and Rece;tors regions, which are phosphorylated by activated insulin receptor and serve as docking sites for proteins containing SH2 domains [ 13 ].
Genetic ablation in mice has shown a predominant role of IRS1 in insulin signalling in skeletal muscle and adipose tissue [ 1415 ] and IRS2 in liver, pancreatic beta cells and neurons [ 16 ]. In addition to signalling through canonical substrates and downstream elements, the insulin receptor and its signalling are also regulated, both positively and negatively, by interaction with membrane and intracellular proteins.
The critical step linking insulin receptor activation to downstream metabolic functions of insulin is the binding of class IA phosphoinositide 3-kinase PI3K to tyrosine-phosphorylated IRS proteins, leading to the formation of phosphatidylinositol 3,4,5 -triphosphate PIP 3.
Downstream effects of PIP 3 lead to activation of 3-phosphoinositide dependent protein kinase PDK 1 and subsequent activation of a variety of kinases, of which Akt1—3 are the best studied, but which also include p70 ribosomal S6 kinase S6Kserum- and glucocorticoid-induced protein kinase SGK and protein kinase C PKC isoforms [ 23 ].
PI3K is a lipid kinase consisting of a catalytic subunit either pα, pβ or pδ encoded by the PIK3CAPIK3CB and PIK3CD genes, respectively and a regulatory subunit either p85α [and its splice variants p55α and p50α], p85β or p55γ encoded by PIK3R1PIK3R2 and PIK3R3 genes, respectively [ 24 ].
The binding of SH2 domains in the regulatory subunits to phosphotyrosines on IRS proteins reduces the constitutive inhibitory effects exerted on the catalytic subunits, leading to increased kinase activity towards phosphatidylinositol 4,5-bisphosphate PIP 2 in the plasma membrane, resulting in PIP 3 formation.
PIP 3 then serves as a docking site for proteins containing pleckstrin-homology domains, including Akt, PDK1 and the mechanistic target of rapamycin complex mTORC 2 component mitogen-activated protein kinase associated protein 1 SIN1which represent critical steps in downstream signalling.
Thus, Akt undergoes PDK1-dependent phosphorylation at T within the kinase domain and mTORC2-dependent phosphorylation at S in a C-terminal hydrophobic motif, resulting in full kinase activation [ 25 ].
In addition to mTORC2, the Akt S residue is phosphorylated by DNA-dependent protein kinase DNA-PK [ 26 ]. While some of these actions occur through phosphorylation of targets, such as GSK3, FOXO1 and mTORC1, Akt also directly phosphorylates proteins in the apoptotic pathway B cell lymphoma 2 [BCL2]-associated agonist of cell death [BAD], X-linked inhibitor of apoptosis [XIAP] and BCL2-interacting mediator of cell death [BIM] and regulates cell division through phosphorylation of cyclin-dependent kinase 2 CDK2 and the cell cycle arrest protein cyclin-dependent kinase inhibitor 1B p27 [ 25 ].
The pleiotropic effects of insulin action on cell growth and metabolism result from a complex interaction between rapid phosphorylation-dependent signalling [ 3536 ] and slower changes in gene expression [ 37 ]. For example, the effect of insulin on glucose transport in skeletal muscle and adipocytes is dependent on the movement of pre-existing vesicles containing GLUT4 glucose transporters to the plasma membrane [ 38 ] and is dependent on AS phosphorylation by Akt [ 39 ], while glycogen synthesis and glycolytic and oxidative glucose metabolism are supported by increased mRNA expression of glycogen synthase 1 [ 40 ], hexokinase 2 [ 41 ] and many components of the mitochondrial electron transport chain [ 42 ].
Insulin also regulates several key mechanisms involved in gene expression, with the regulation of mRNA transcription being the best studied [ 43 ]. This important aspect of insulin action is accomplished by insulin-induced changes in phosphorylation, expression, processing and translocation of a variety of transcription factors, leading to stimulation or inhibition of gene transcription.
FOX proteins represent a large family of transcription factors, of which FOXOs FOXO1, FOXO3, FOXO4 and FOXO6 are the most well-characterised regulators of downstream insulin signalling. Here, the effect of insulin is one of negative regulation Fig.
This creates interaction sites for FOXOs with phosphoserine-binding proteins, resulting in their retention in the cytoplasm and decreased transcriptional activity in the nucleus [ 4445 ]. Thus, insulin-induced phosphorylation of FOXOs results in reduced hepatic gluconeogenesis [ 46 ], inhibition of muscle autophagy and protein degradation [ 3047 ] and regulation of adipocyte differentiation [ 48 ].
Reciprocal regulation of FOX transcription factors by insulin. a Under feeding or other conditions where insulin action is high, FOXOs are phosphorylated by Akt on serine residues, creating interaction sites for proteins, leading to cytoplasmic retention and inhibited transcriptional activity.
Under these conditions, increased Akt and mTORC1 activity inhibits GSK3 signalling and relieves FOXKs from inhibitory GSK3-mediated phosphorylation, leading to increased nuclear translocation and FOXK transcriptional activity.
Under these conditions, increased GSK3 activity leads to increased FOXK phosphorylation and interaction with phosphoserine-binding proteins, resulting in cytoplasmic retention and decreased transcriptional activity.
Line thickness indicates strength of signalling activity, with thicker lines indicating stronger signalling activity. Another emerging class of FOX proteins that act in insulin signalling are the FOXK1 and FOXK2 transcription factors [ 2152 ].
In contrast to FOXOs, which are turned off by insulin, FOXKs display increased nuclear localisation and transcriptional activity following insulin stimulation Fig. In the basal state, GSK3 phosphorylates FOXKs leading to increased interaction with proteins and nuclear exclusion Fig.
In hepatocytes, FOXKs regulate genes involved in the cell cycle, apoptosis and lipid metabolism [ 21 ], while in adipocytes and muscle, FOXKs promote glucose transport and lactate production by stimulation of glycolytic metabolism and inhibition of mitochondrial pyruvate oxidation [ 53 ].
In addition to phosphorylation, insulin also regulates the expression and processing of transcription factors. For example, sterol regulatory element binding proteins SREBP 1 and 2 are important regulators of triacylglycerol and cholesterol synthesis and are synthesised as precursors that reside in the endoplasmic reticulum ER.
A re-emerging concept in insulin control of gene expression is the possibility of direct effects of the insulin receptor itself.
Studies from over 40 years ago showed binding of insulin to nuclear preparations [ 55 ]. The significance of such findings has only come to light by recent studies demonstrating interactions between the insulin receptor and FOXK1 [ 21 ] and interactions of the insulin receptor with RNA polymerase II Pol II on DNA in the nucleus [ 56 ].
Indeed, chromatin immunoprecipitation followed by sequencing ChIP-seq analysis of HepG2 hepatocytes revealed ~ peaks bound by the insulin receptor, many overlapping with Pol II sites on promoters. These occur in genes involved in a variety of cellular functions including lipid metabolism, translation and immunity, as well as genes involved in pathophysiological states, such as diabetes.
Type 2 diabetes affects more than million adults worldwide and its prevalence continues to increase at epidemic rates, thus posing one of the greatest public health challenges to society [ 57 ].
This is the result of both genetic and environmental factors. While it remains debated whether insulin resistance and relative beta cell failure constitute the primary defect in type 2 diabetes [ 5859 ], a 25 year prospective longitudinal study of people at high genetic risk of developing type 2 diabetes has demonstrated that insulin resistance precedes and predicts disease development [ 60 ].
Likewise, family studies have shown that glucose tolerant offspring of parents with type 2 diabetes show insulin resistance, while loss of first-phase insulin secretion was observed in those that developed impaired glucose tolerance [ 61 ].
Clamp and MRI studies have revealed skeletal muscle as a primary site of insulin resistance in the offspring of parents with type 2 diabetes, with the muscle of these individuals exhibiting reduced glucose uptake and reduced glycogen synthesis before hyperglycaemia develops [ 62 ].
This impaired glucose metabolism has been attributed to a number of defects, including decreased glucose transport [ 63 ], lower rates of insulin-induced ATP production [ 42 ] and reduced expression of genes involved in mitochondrial function [ 6465 ].
The major question that remains is what are the fundamental defects leading to insulin resistance and how do cell-intrinsic vs cell-extrinsic factors contribute to these defects? Conversely, cell-intrinsic factors are those that persist after removal or normalisation of all extrinsic factors.
These are most likely due to genetic or epigenetic effects, but may or may not be in the insulin signalling pathway itself. How each of these might contribute to insulin resistance in type 2 diabetes is discussed in the following sections. In type 2 diabetes, most attention has focused on extrinsic factors contributing to insulin resistance, including the role of adipose tissue, circulating metabolites, inflammatory signals and the gut microbiome [ 666768 ] Fig.
Accumulation of ceramides can also activate protein phosphatase 2A PP2A and PKCζ, inhibiting Akt2. Adipose tissue expansion is also associated with increased adipose tissue inflammation and hypoxia [ 77 ], promoting recruitment of proinflammatory macrophages [ 78 ] that secrete cytokines, such as TNF-α and IL-6, which further worsen insulin resistance by activation of the TNF-α receptor TNFR and other cytokine receptors [ 79 ].
Extrinsic factors contributing to insulin resistance. Several environmental factors may lead to systemic changes affecting multiple tissues and contributing to impaired insulin signalling. Obesity negatively correlates with circulating levels of adiponectin [ ] and signalling lipids with beneficial properties, such as 12,dihydroxy-9Z-octadecenoic acid 12,diHOME [ ] and branched fatty acid esters of hydroxy fatty acids FAHFAs [ ].
Overnutrition leads to adipose tissue expansion and increased release of cytokines and other inflammatory mediators e. JNK, IKK and novel PKCs [nPKCs] and increased IRS serine phosphorylation, and due to increased transcription of SOCS proteins, which interfere with IRS tyrosine phosphorylation.
Adipose tissue insulin resistance is associated with ectopic lipid accumulation, mitochondrial dysfunction and reactive oxygen species ROS generation, and ER stress in insulin-sensitive tissues. Adipose tissue expansion in obesity may also have an impact on systemic metabolism through altered release of exosomal miRNAs.
Insulin signalling proteins are shown in blue and intracellular mediators of cytokine receptors and other stress signals are shown in green. DAG, diacylglycerol; IRE1, inositol-requiring enzyme 1; JAK, Janus kinase; STAT, signal transducer and activator of transcription; TLR4, Toll-like receptor 4; TNFR, TNF-α receptor; UPR, unfolded protein response; XBP1, X-box binding protein 1.
Circulating branched-chain amino acids BCAAs and aromatic amino acids isoleucine, leucine, valine, phenylalanine and tyrosine are also associated with insulin resistance [ 67 ], and lowering BCAA levels can improve insulin sensitivity, at least in mice [ 83 ]. Gut microbiota may also play a role in regulating BCAA supply, as well as the production of short-chain fatty acids and other metabolites, which, in turn, have an impact on systemic insulin sensitivity [ 85 ].
Recently, we and others have shown that adipose tissue can also crosstalk with other tissues through secretion of exosomal microRNAs miRNAs [ 8889 ]; however, how this fits in the regulation of insulin sensitivity at a signalling level remains to be determined.
In vitro approaches, where cells are cultured under controlled conditions, provides an opportunity to minimise the influence of extrinsic factors and isolate cell-autonomous determinants of insulin resistance, which are more closely linked to the genetic and epigenetic alterations underlying type 2 diabetes.
Skeletal muscle biopsies and primary cultured myoblasts derived from people with type 2 diabetes show insulin resistance and several metabolic defects. However, primary cell models have limited usefulness for the definition of molecular mechanisms underlying insulin resistance due to limits in expandability and ability for screening using RNA interference RNAichemical genetics or CRISPR.
: Insulin sensitivity and insulin receptors| INCREASED EXPRESSION OF p85α | In this case, it is insuoin SH2 domain sensitivihy PI-3 kinase Insulin sensitivity and insulin receptors that binds the P-Tyr of IRS Wnd Endocrinol Metab. Akerman, I. The Journal of Clinical Endocrinology and Metabolism. Blood— Obesity inhibited miR expression in adipose tissue macrophages ATMsand miR was shown to target Delta-like-4 DLL4a Notch1 ligand is associated with ATM inflammation. Myers, M. |
| Defining the underlying defect in insulin action in type 2 diabetes | Diabetologia | Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. This article is cited by Long-term exposure to ambient fine particulate components and leukocyte epigenome-wide DNA Methylation in older men: the Normative Aging Study Cuicui Wang Heresh Amini Joel D. Science , — Tyrosine phosphorylation of the YXXΦ motifs is expected to disrupt the IRS—AP2M1 interaction by introducing both static hindrance and unfavorable electrostatic interactions. Structure, function and diversity of the healthy human microbiome. |
| Introduction | Zaharia OP, Strassburger K, Strom A et al Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Proc Natl Acad Sci U S A 12 — Birnbaum MJ: Turning down insulin signaling. Protein concentration was determined using bicinchoninic acid assay Thermo Fisher Scientific. Sharma, … Laura C. Diabetes 51 , — Published in Volume 4, Issue 15 on August 8, JCI Insight. |
Video
The Causes of Insulin Resistance - #Shorts Boris Draznin; Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Cognitive enhancement strategies and Increased Receptorrs of Antioxidant rich diet : The Two Insulon of Sensigivity Coin. Diabetes 1 August Holistic anxiety remedies 55 8 : — Initial attempts to unravel the molecular mechanism of insulin resistance have strongly suggested that a defect responsible for insulin resistance in the majority of patients lies at the postreceptor level of insulin signaling. However, the nature of the triggering event s remains largely enigmatic. Two separate, but likely, complementary mechanisms have recently emerged as a potential explanation.
Insulin sensitivity and insulin receptors -
Diabetes 31 , — Barbour, L. A Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30 , S—S Parichatikanond, W.
Prolonged stimulation of β2-adrenergic receptor with β2-agonists impairs insulin actions in H9c2 cells. Walli, R. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIVinfected patients. AIDS 12 , F—F Murata, H.
The mechanism of insulin resistance caused by HIV protease inhibitor therapy. Teff, K. Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.
Diabetes 62 , — Bittencourt, M. Insulin therapy in insulin resistance: could it be part of a lethal pathway? Elbein, S. Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. Shulman, G. Cellular mechanisms of insulin resistance.
Knauf, C. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. Petersen, M.
Regulation of hepatic glucose metabolism in health and disease. Matsumoto, M. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.
Shimomura, I. Cell 6 , 77—86 Petersen, K. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. Henriksen, E. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Drug Targets 7 , — Karim, S. Hepatic expression and cellular distribution of the glucose transporter family.
World J. Rencurel, F. Requirement of glucose metabolism for regulation of glucose transporter type 2 GLUT2 gene expression in liver. Thorens, B. Diabetologia 58 , — Eberlé, D. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 , — Horton, J.
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Ferré, P. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Tobe, K. Dentin, R. Carbohydrate responsive element binding protein ChREBP and sterol regulatory element binding protein-1c SREBP-1c : two key regulators of glucose metabolism and lipid synthesis in liver.
Biochimie 87 , 81—86 Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. Herman, M. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
Iizuka, K. Deficiency of carbohydrate response element-binding protein ChREBP reduces lipogenesis as well as glycolysis. Natl Acad.
Jaworski, K. Regulation of triglyceride metabolism. Hormonal regulation of lipolysis in adipose tissue. Liver Physiol. Vaughan, M. Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue.
Zmuda-Trzebiatowska, E. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes.
Cell Signal 18 , — Choi, Y. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B—null mice. Martinez-Botas, J. Genet 26 , — Tansey, J. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity.
USA 98 , — Mechanisms of Insulin Action and Insulin Resistance. Kimball, S. Regulation of protein synthesis by insulin. Pösö, A. Multifunctional control of amino acids of deprivation-induced proteolysis in liver.
Role of leucine. Marshall, S. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids.
Rudrappa, S. Human skeletal muscle disuse atrophy: effects on muscle protein synthesis, breakdown, and insulin resistance-a qualitative review.
Front Physiol. Medeiros, C. Antuna-Puente, B. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. Rabe, K. Adipokines and insulin resistance. Adipokines mediate inflammation and insulin resistance.
Lausanne 4 , 71 Li, S. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA , — Hotta, K. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.
Diabetes 50 , — Takahashi, M. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett.
Yamauchi, T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Li, L. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
Diabetes , — Soriguer, F. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Yue, P. Apelin is necessary for the maintenance of insulin sensitivity.
American journal of physiology. Apelin decreases lipolysis via G q , G i , and AMPK-dependent mechanisms. Endocrinology , 59—68 Segal, K. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men.
Amitani, M. The role of leptin in the control of insulin-glucose axis. Front Neurosci. Article PubMed PubMed Central CAS Google Scholar. Ceddia, R. Analysis of paradoxical observations on the association between leptin and insulin resistance.
Covey, S. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Seufert, J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53 , S—S Myers, M. Mechanisms of leptin action and leptin resistance. Burguera, B.
Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Gainsford, T. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.
USA 93 , — Scherer, P. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 , — Saponaro, C. The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7 , — Frayn, K. Adipose tissue and the insulin resistance syndrome.
Roden, M. Mechanism of free fatty acid-induced insulin resistance in humans. Invest 97 , — Goossens, G. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. RANDLE, P. The glucose fatty-acid cycle.
Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 , — Randle, P. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Y Acad. Brechtel, K. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study.
Reson Med 45 , — Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
Diabetes 46 , 3—10 Rothman, D. USA 92 , — Cline, G. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. Dresner, A. Effects of free fatty acids on glucose transport and IRSassociated phosphatidylinositol 3-kinase activity.
Yu, C. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 IRS-1 -associated phosphatidylinositol 3-kinase activity in muscle. Erion, D. Diacylglycerol-mediated insulin resistance. Kim, J. PKC-theta knockout mice are protected from fat-induced insulin resistance.
Nagai, Y. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Yen, C. The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters.
Lipid Res. Timmers, S. Muscular diacylglycerol metabolism and insulin resistance. Liu, L. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. Sokolowska, E. The Role of Ceramides in Insulin Resistance.
Lausanne 10 , Schubert, K. Chaurasia, B. Trends Endocrinol. Stiban, J. Ceramide synthases: roles in cell physiology and signaling. Med Biol. Stöckli, J. Metabolomic analysis of insulin resistance across different mouse strains and diets. Blachnio-Zabielska, A.
The crucial role of CCer in fat-induced skeletal muscle insulin resistance. Biochem 40 , — Raichur, S. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.
Turpin, S. Obesity-induced CerS6-dependent C ceramide production promotes weight gain and glucose intolerance. Holland, W. An FGFadiponectin-ceramide axis controls energy expenditure and insulin action in mice. Mente, A. Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population.
PLoS One 8 , e Brown, A. Genetics of Insulin Resistance and the Metabolic Syndrome. Chen, Z. Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes. Shakhanova, A. Association of polymorphism genes LPL , ADRB2 , AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population.
Henkin, L. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Parks, B. Genetic architecture of insulin resistance in the mouse. Xue, A. Genome-wide association analyses identify risk variants and putative regulatory mechanisms for type 2 diabetes.
Yousef, A. IRS-1 genetic polymorphism r. Appl Clin. Genet 11 , 99— Hashemian, L. The role of the PPARG Pro12Ala common genetic variant on type 2 diabetes mellitus risk.
Zeng, Q. Association Between Insulin-like Growth Factor-1 rs Polymorphism and Type 2 Diabetes Mellitus Susceptibility: A Meta-Analysis. Front Genet 12 , Knowles, J. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. Invest , Richards, J. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.
PLoS Genet 5 , e Eichler, E. Missing heritability and strategies for finding the underlying causes of complex disease. Genet 11 , — Flannick, J. Exome sequencing of 20, cases of type 2 diabetes and 24, controls. Nature , 71—76 Viñuela, A. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D.
Metz, S. The Arg82Cys polymorphism of the protein nepmucin implies a role in HDL metabolism. Moltke, I. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes.
Huypens, P. Epigenetic germline inheritance of diet-induced obesity and insulin resistance. Genet 48 , — Ling, C. Epigenetics in human obesity and type 2 diabetes. Ahmed, S. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.
Epigenetics 12 , 1—23 Cierzniak, A. DNA methylation in adipocytes from visceral and subcutaneous adipose tissue influences insulin-signaling gene expression in obese individuals. Int J. Epigenetic regulation of insulin action and secretion-role in the pathogenesis of type 2 diabetes.
Intern Med , — Zhao, J. Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Zhou, Z. DNA methylation landscapes in the pathogenesis of type 2 diabetes mellitus. DNA methylation Landsc.
pathogenesis type 2 diabetes Mellit. Liu, J. An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis. Commu 10 , 1—11 CAS Google Scholar.
Gu, T. DNA methylation analysis of the insulin-like growth factor-1 IGF1 gene in Swedish men with normal glucose tolerance and type 2 diabetes.
Wittenbecher, C. Insulin-like growth factor binding protein 2 IGFBP-2 and the risk of developing type 2 diabetes. Diabetes 68 , — Haywood, N. Crujeiras, A. Genome-wide DNA methylation pattern in visceral adipose tissue differentiates insulin-resistant from insulin-sensitive obese subjects.
Res , 13—24 Ma, X. Functional implications of DNA methylation in adipose biology. Gao, H. Long non-coding RNAs associated with metabolic traits in human white adipose tissue. EBioMedicine 30 , — Altered adipose tissue DNA methylation status in metabolic syndrome: relationships between global DNA methylation and specific methylation at adipogenic, lipid metabolism and inflammatory candidate genes and metabolic variables.
Article CAS PubMed Central Google Scholar. Samblas, M. DNA methylation markers in obesity, metabolic syndrome, and weight loss. Epigenetics 14 , — Naidoo, V. Cell-and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.
Ali, M. DNA methylation profile of genes involved in inflammation and autoimmunity correlates with vascular function in morbidly obese adults. Epigenetics 17 , 93— Panchal, S.
DNA methylation in adipose tissue and metabolic syndrome. Petrus, P. Adipocyte expression of SLC19A1 links DNA hypermethylation to adipose tissue inflammation and insulin resistance. Ramos-Lopez, O. DNA methylation signatures at endoplasmic reticulum stress genes are associated with adiposity and insulin resistance.
Genet Metab. Zhang, Y. Methylation of HIF3A promoter CpG islands contributes to insulin resistance in gestational diabetes mellitus. Genet Genom. van Dijk, S. DNA methylation in blood from neonatal screening cards and the association with BMI and insulin sensitivity in early childhood.
Endoplasmic reticulum stress epigenetics is related to adiposity, dyslipidemia, and insulin resistance. Adipocyte 7 , — Stillman, B. Histone modifications: insights into their influence on gene expression.
Cell , 6—9 Małodobra-Mazur, M. Histone modifications influence the insulin-signaling genes and are related to insulin resistance in human adipocytes. Biochem Cell Biol. Davegårdh, C. DNA methylation in the pathogenesis of type 2 diabetes in humans. David, V. Gluco-incretinsregulate beta-cell glucose competence by epigenetic silencing of fxyd3expression.
PLoS ONE 9 , e Emamgholipour, S. Acetylation and insulin resistance: a focus on metabolic and mitogenic cascades of insulin signaling. Lab Sci. Zhou, S. Sirtuins and insulin resistance. Human adipose tissue H3K4me3 histone mark in adipogenic, lipid metabolism and inflammatory genes is positively associated with BMI and HOMA-IR.
PloS one 14 , e Maude, H. Epigenetics of Hepatic Insulin Resistance. Cech, T. The noncoding RNA revolution-trashing old rules to forge new ones. Cell , 77—94 Formichi, C. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases.
Ghafouri-Fard, S. The expression profile and role of non-coding RNAs in obesity. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Lausanne 9 , Agbu, P. MicroRNA-mediated regulation of glucose and lipid metabolism. Poy, M. A pancreatic islet-specific microRNA regulates insulin secretion.
Jiménez-Lucena, R. Lee, C. Foxa2 controls Pdx1 gene expression in pancreatic β-cells in vivo. Diabetes 51 , — Xu, G. Thioredoxin-interacting protein regulates insulin transcription through microRNA Med 19 , — Bao, L. MicroRNA targets SOCS3 to inhibit beta-cell dysfunction in diabetes.
PloS One 10 , e Iacomino, G. Role of microRNAs in obesity and obesity-related diseases. Genes Nutr. Suksangrat, T. miRNA regulation of glucose and lipid metabolism in relation to diabetes and non-alcoholic fatty liver disease.
Chen, Y. miRNA inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.
Zhou, Y. MicroRNAa induces insulin resistance by targeting PPARδ in skeletal muscle cells. Wang, S. Li, C. Decreased glycogenolysis by miRp promotes regional glycogen accumulation within the spinal cord of amyotrophic lateral sclerosis mice. Front Mol. Zheng, H. MicroRNAp inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Theranostics 11 , Wagschal, A. Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. Rayner, K. MiR contributes to the regulation of cholesterol homeostasis. Goedeke, L. MicroRNAa regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.
Soh, J. MicroRNAc reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Salerno, A. LDL Receptor Pathway Regulation by miR and miRd. Front Cardiovasc Med. Miranda, K. MicroRNA modulates metabolic inflammation by regulating Notch signaling in adipose tissue macrophages.
Wang, Y. Natural killer cell-derived exosomal miRp attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct.
Target Ther. Quinn, J. Unique features of long non-coding RNA biogenesis and function. Genet 17 , 47—62 Squillaro, T. Long non-coding RNAs in regulation of adipogenesis and adipose tissue function. Elife 9 , e Zhang, T. Regulation of glucose and lipid metabolism by long non-coding RNAs: facts and research progress.
Lausanne 11 , Yang, S. LncRNA SRA deregulation contributes to the development of atherosclerosis by causing dysfunction of endothelial cells through repressing the expression of adipose triglyceride lipase.
Med Rep. Zhang, N. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia.
JCI insight 3 , e Article PubMed Central Google Scholar. Gui, W. LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1.
Cell Commun. Akerman, I. Human pancreatic β cell lncRNAs control cell-specific regulatory networks. Xiong, L. LncRNA-Malat1 is involved in lipotoxicity-induced ß-cell dysfunction and the therapeutic effect of exendin-4 via Ptbp1.
Ruan, Y. Circulating LncRNAs analysis in patients with type 2 diabetes reveals novel genes influencing glucose metabolism and Islet β-cell function.
Biochem 46 , — Zhang, F. The long non-coding RNA βFaar regulates islet β-cell function and survival during obesity in mice. Li, M. A putative long noncoding RNA-encoded micropeptide maintains cellular homeostasis in pancreatic β cells. Nucleic Acids 26 , — Li, X.
The biogenesis, functions, and challenges of circular RNAs. Cell 71 , — Zaiou, M. The emerging role and promise of circular RNAs in obesity and related metabolic disorders.
Cells 9 , Stoll, L. A circular RNA generated from an intron of the insulin gene controls insulin secretion. Circular RNAs as novel regulators of β-cell functions in normal and disease conditions.
Cai, H. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miRp and upregulating transcription factor forkhead box O1. Endocr J. Sun, R. Chen, C. Regulatory roles of circRNAs in adipogenesis and lipid metabolism: emerging insights into lipid-related diseases. FEBS J.
Li, A. Identification and characterization of CircRNAs of two pig breeds as a new biomarker in metabolism-related diseases. Biochem 47 , — Arcinas, C.
Adipose circular RNAs exhibit dynamic regulation in obesity and functional role in adipogenesis. Lin, X. Front Cell Dev. Li, Q. CircACC1 Regulates Assembly and Activation of AMPK Complex under Metabolic Stress. e7 Du, R. Med 20 , Nayfach, S.
New insights from uncultivated genomes of the global human gut microbiome. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature , Derrien, M. The gut microbiota in the first decade of life. Trends Microbiol 27 , — Rinninella, E.
What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7 , 14 David, L. Diet rapidly and reproducibly alters the human gut microbiome.
Shi, Z. Gut microbiota: An important link between western diet and chronic diseases. Nutrients 11 , Quiroga, R. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Clauss, M. Interplay between exercise and gut microbiome in the context of human health and performance.
Front Nutr. Matenchuk, B. Sleep, circadian rhythm, and gut microbiota. Ramirez, J. Antibiotics as major disruptors of gut microbiota. Front Cell Infect. Microbiol 10 , Awany, D. Host and microbiome genome-wide association studies: current state and challenges. Front Genet 9 , Cahana, I.
Impact of host genetics on gut microbiome: Take-home lessons from human and mouse studies. Model Exp. Gut microbiome and its role in obesity and insulin resistance.
Gérard, C. Impact of gut microbiota on host glycemic control. Del Chierico, F. Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study.
Acta Diabetol. Wu, H. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Andoh, A. Biochem Nutr. Agus, A. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Gut 70 , — Martin, A. The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Scheithauer, T. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes.
Front Immunol. de Groot, P. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
Gut 69 , — Salles, B. Probiotics supplementation and insulin resistance: a systematic review. Johnson, J. On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes. Diabetologia 64 , — Lots of blood sugar in the bloodstream is very damaging to the body and needs to be moved into cells as soon as possible.
Yep, weight gain. You do not have to be overweight to have insulin resistance. If you have insulin resistance, you want to become the opposite—more insulin sensitive cells are more effective at absorbing blood sugar so less insulin is needed.
These lifestyle changes really work. Talk with your health care provider about how to get started. Skip directly to site content Skip directly to search. Español Other Languages. Insulin Resistance and Diabetes. Spanish Print. Minus Related Pages. Insulin acts like a key to let blood sugar into cells for use as energy.
Insulin, Blood Sugar, and Type 2 Diabetes Insulin is a key player in developing type 2 diabetes. Here are the high points: The food you eat is broken down into blood sugar. Blood sugar enters your bloodstream, which signals the pancreas to release insulin.
Insulin also signals the liver to store blood sugar for later use. Blood sugar enters cells, and levels in the bloodstream decrease, signaling insulin to decrease too.
But this finely tuned system can quickly get out of whack, as follows: A lot of blood sugar enters the bloodstream. The pancreas pumps out more insulin to get blood sugar into cells. The pancreas keeps making more insulin to try to make cells respond. Do You Have Insulin Resistance?
Research Article Rexeptors Therapeutics Insulin sensitivity and insulin receptors access Discovery, Preclinical and Early Development, MRL, Merck and Co. Address correspondence to: James Mu, Gateway Blvd. Phone: Find articles by Wang, Y.
Nach meiner Meinung irren Sie sich. Es ich kann beweisen. Schreiben Sie mir in PM.
Nach meinem ist es das sehr interessante Thema. Ich biete Ihnen es an, hier oder in PM zu besprechen.